Duff SB, Mordin MM. Strategies for assessing health economic and quality-of-life outcomes in multiple sclerosis. Expert Rev Pharmacoecon Outcomes Res. 2002 Dec;2(6):577-87.
Sacco P, Luo R, Chang S, Sung D, Gause D. Potential benefits of rivastigmine in the nursing home population with alzheimer's disease. Poster presented at the Gerontological Society of America; December 2002. Boston, MA.
Ofman J, Hauber B, Deal L, Mauskopf J, Snyder E. Costs and benefits of rivastigmine treatment for Alzheimer's disease in the US. Neurobiol Aging. 2002 Jan 1;23(1):476.
Rothman KJ, Funch D, Dreyer NA. Bromocriptine and puerperal seizures. Epidemiology. 1990 May;1(3):232-8.